cik stringclasses 1
value | date stringlengths 8 8 | form stringclasses 4
values | sentenceCount int64 0 2.33k | sentence stringlengths 2 5.25k | filename stringlengths 40 40 |
|---|---|---|---|---|---|
0000320193 | 20170201 | 10-Q | 692 | In November 2016, the purchase period for this ASR ended and an additional 4.4 million shares were delivered and retired. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 693 | In total, 26.9 million shares were delivered under this ASR at an average repurchase price of $111.73. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 694 | (3)
In November 2016, the Company entered into a new ASR to purchase up to $6.0 billion of the Company’s common stock. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 695 | In exchange for an up-front payment of $6.0 billion, the financial institution party to the arrangement committed to deliver shares to the Company during the ASR’s purchase period, which will end in February 2017. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 696 | The total number of shares ultimately delivered, and therefore the average price paid per share, will be determined at the end of the applicable purchase period based on the volume weighted-average price of the Company’s common stock during that period. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 697 | Item 3. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 698 | Defaults Upon Senior Securities
None. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 699 | Item 4. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 700 | Mine Safety Disclosures
Not applicable. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 701 | Item 5. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 702 | Other Information
None. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 703 | Item 6. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 704 | Exhibits
Index to Exhibits
Incorporated by Reference
Exhibit
Number
Exhibit Description
Form
Exhibit
Filing Date/
Period End Date
3.2
Amended and Restated Bylaws of the Registrant effective as of December 13, 2016. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 705 | 8-K
3.2
12/13/16
10.18*
Form of Restricted Stock Unit Award Agreement under 2014 Employee Stock Plan effective as of October 14, 2016. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 706 | 10-K
10.18
9/24/2016
10.19*
Form of Performance Award Agreement under 2014 Employee Stock Plan effective as of October 14, 2016. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 707 | 10-K
10.19
9/24/2016
31.1**
Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 708 | 31.2**
Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 709 | 32.1***
Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 710 | 101.INS**
XBRL Instance Document. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 711 | 101.SCH**
XBRL Taxonomy Extension Schema Document. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 712 | 101.CAL**
XBRL Taxonomy Extension Calculation Linkbase Document. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 713 | 101.DEF**
XBRL Taxonomy Extension Definition Linkbase Document. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 714 | 101.LAB**
XBRL Taxonomy Extension Label Linkbase Document. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 715 | 101.PRE**
XBRL Taxonomy Extension Presentation Linkbase Document. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 716 | *
Indicates management contract or compensatory plan or arrangement. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 717 | **
Filed herewith. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 718 | ***
Furnished herewith. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 719 | SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. | 0001628280-17-000717/full-submission.txt |
0000320193 | 20170201 | 10-Q | 720 | February 1, 2017
Apple Inc.
By:
/s/ Luca Maestri
Luca Maestri
Senior Vice President,
Chief Financial Officer | 0001628280-17-000717/full-submission.txt |
0000320193 | 20230505 | 10-Q | 0 | 10-Q aapl-20230401.htm 10-Q
aapl-20230401false2023Q20000320193--09-30P1Y65P1Y26P1Y72
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 1, 2023
or
☐ TR... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 1 | Commission File Number: 001-36743
Apple Inc.
(Exact name of Registrant as specified in its charter)
California 94-2404110
(State or other jurisdiction
of incorporation or organization) (I.R.S. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 2 | Employer Identification No.) | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 3 | One Apple Park Way
Cupertino, California
(Address of principal executive offices) (Zip Code)
(408) 996-1010
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s) Name of each exchange on which registered
Common Stock, $0.00... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 4 | Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 5 | Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 6 | See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 7 | Large accelerated filer ☒ Accelerated filer ☐
Non-accelerated filer ☐ Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards p... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 8 | ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 9 | Yes ☐ No ☒
15,728,702,000 shares of common stock were issued and outstanding as of April 21, 2023. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 10 | Apple Inc.
Form 10-Q
For the Fiscal Quarter Ended April 1, 2023
PART I - FINANCIAL INFORMATION
Item 1. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 11 | Financial Statements
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares which are reflected in thousands and per share amounts)
See accompanying Notes to Condensed Consolidated Financial Statements. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 12 | Apple Inc. | Q2 2023 Form 10-Q | 1
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
See accompanying Notes to Condensed Consolidated Financial Statements. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 13 | Apple Inc. | Q2 2023 Form 10-Q | 2
Apple Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares which are reflected in thousands and par value)
See accompanying Notes to Condensed Consolidated Financial Statements. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 14 | Apple Inc. | Q2 2023 Form 10-Q | 3
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (Unaudited)
(In millions, except per share amounts)
See accompanying Notes to Condensed Consolidated Financial Statements. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 15 | Apple Inc. | Q2 2023 Form 10-Q | 4
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
See accompanying Notes to Condensed Consolidated Financial Statements. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 16 | Apple Inc. | Q2 2023 Form 10-Q | 5
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 - Summary of Significant Accounting Policies
Basis of Presentation and Preparation
The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (c... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 17 | Intercompany accounts and transactions have been eliminated. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 18 | In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 19 | The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 20 | Actual results could differ materially from those estimates. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 21 | Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 22 | These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 24, 2022. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 23 | The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 24 | An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters, which occurred in the first fiscal quarter of 2023. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 25 | The Company’s fiscal years 2023 and 2022 span 53 and 52 weeks, respectively. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 26 | Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 27 | Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended April 1, 2023 and March 26, 2022 (net income in millions and shares in thousands):
Approximately 48 million restricted stock units (“RSUs”) were excluded from the computation o... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 28 | Apple Inc. | Q2 2023 Form 10-Q | 6
Note 2 - Revenue
Net sales disaggregated by significant products and services for the three- and six-month periods ended April 1, 2023 and March 26, 2022 were as follows (in millions):
Total net sales include $3.5 billion of revenue recognized in the three months ended April 1, 2023 t... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 29 | The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 10, “Segment Information and Geographic Data” for the three- and six-month periods ended April 1, 2023 and March 26, 2022, except in Greater China, where iPhone revenue represented a modera... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 30 | As of April 1, 2023 and September 24, 2022, the Company had total deferred revenue of $12.5 billion and $12.4 billion, respectively. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 31 | As of April 1, 2023, the Company expects 65% of total deferred revenue to be realized in less than a year, 26% within one-to-two years, 7% within two-to-three years and 2% in greater than three years. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 32 | Note 3 - Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of April 1, 2023 and September 24, 2022 (in millions):
Apple Inc. | Q2 2023 Form 10-Q | 7
(1)Level 1 fair value e... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 33 | (2)Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for subst... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 34 | (3)As of April 1, 2023 and September 24, 2022, total marketable securities included $13.1 billion and $12.7 billion, respectively, that were restricted from general use, related to the State Aid Decision (refer to Note 5, “Income Taxes”) and other agreements. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 35 | The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of April 1, 2023 (in millions):
Derivative Instruments and Hedging
The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 36 | However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 37 | There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 38 | Foreign Exchange Risk
To protect gross margins from fluctuations in foreign currency exchange rates, the Company may enter into forward contracts, option contracts or other instruments, and may designate these instruments as cash flow hedges. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 39 | The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 40 | To protect the Company’s foreign currency-denominated term debt or marketable securities from fluctuations in foreign currency exchange rates, the Company may enter into forward contracts, cross-currency swaps or other instruments. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 41 | The Company designates these instruments as either cash flow or fair value hedges. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 42 | As of April 1, 2023, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for term debt-related foreign currency transactions is 19 years. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 43 | Apple Inc. | Q2 2023 Form 10-Q | 8
The Company may also enter into derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign currency exchange rates, as well as to offset a portion of the foreign currency exchange gains and losses generated by the ... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 44 | Interest Rate Risk
To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may enter into interest rate swaps, options or other instruments. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 45 | The Company designates these instruments as either cash flow or fair value hedges. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 46 | The notional amounts of the Company’s outstanding derivative instruments as of April 1, 2023 and September 24, 2022 were as follows (in millions):
The gross fair values of the Company’s derivative assets and liabilities as of September 24, 2022 were as follows (in millions):
(1)Derivative assets are measured using Leve... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 47 | (2)Derivative liabilities are measured using Level 2 fair value inputs and are included in other current liabilities and other non-current liabilities in the Condensed Consolidated Balance Sheet. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 48 | The derivative assets above represent the Company’s gross credit exposure if all counterparties failed to perform. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 49 | To mitigate credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair values of certain derivatives fluctuate from contractually established thresholds. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 50 | To further limit credit risk, the Company generally enters into master netting arrangements with the respective counterparties to the Company’s derivative contracts, under which the Company is allowed to settle transactions with a single net amount payable by one party to the other. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 51 | As of September 24, 2022, the potential effects of these rights of set-off associated with the Company’s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $7.8 billion, resulting in a net derivative asset of $412 million. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 52 | The carrying amounts of the Company’s hedged items in fair value hedges as of April 1, 2023 and September 24, 2022 were as follows (in millions):
Apple Inc. | Q2 2023 Form 10-Q | 9
Accounts Receivable
Trade Receivables
The Company has considerable trade receivables outstanding with its third-party cellular network carr... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 53 | The Company generally does not require collateral from its customers; however, the Company will require collateral or third-party credit support in certain instances to limit credit risk. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 54 | In addition, when possible, the Company attempts to limit credit risk on trade receivables with credit insurance for certain customers or by requiring third-party financing, loans or leases to support credit exposure. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 55 | These credit-financing arrangements are directly between the third-party financing company and the end customer. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 56 | As such, the Company generally does not assume any recourse or credit risk sharing related to any of these arrangements. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 57 | As of both April 1, 2023 and September 24, 2022, the Company had one customer that represented 10% or more of total trade receivables, which accounted for 10%. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 58 | The Company’s cellular network carriers accounted for 32% and 44% of total trade receivables as of April 1, 2023 and September 24, 2022, respectively. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 59 | Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 60 | The Company purchases these components directly from suppliers. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 61 | As of April 1, 2023, the Company had three vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 43%, 19% and 13%. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 62 | As of September 24, 2022, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 54% and 13%. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 63 | Note 4 - Condensed Consolidated Financial Statement Details
The following tables show the Company’s condensed consolidated financial statement details as of April 1, 2023 and September 24, 2022 (in millions):
Inventories
Property, Plant and Equipment, Net
Other Income/(Expense), Net
The following table shows the detail... | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 64 | The State Aid Decision ordered Ireland to calculate and recover additional taxes from the Company for the period June 2003 through December 2014. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 65 | Irish legislative changes, effective as of January 2015, eliminated the application of the tax opinions from that date forward. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 66 | The Company and Ireland appealed the State Aid Decision to the General Court of the Court of Justice of the European Union (the “General Court”). | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 67 | On July 15, 2020, the General Court annulled the State Aid Decision. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 68 | On September 25, 2020, the European Commission appealed the General Court’s decision to the European Court of Justice and a hearing has been scheduled for May 23, 2023. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 69 | The Company believes it would be eligible to claim a U.S. foreign tax credit for a portion of any incremental Irish corporate income taxes potentially due related to the State Aid Decision. | 0000320193-23-000064/full-submission.txt |
0000320193 | 20230505 | 10-Q | 70 | Note 6 - Debt
Commercial Paper
The Company issues unsecured short-term promissory notes (“Commercial Paper”) pursuant to a commercial paper program. | 0000320193-23-000064/full-submission.txt |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.